- Home
- BELFA vs GPCR Comparison
BELFA vs GPCR Comparison
Compare BELFA & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BELFA
- GPCR
- Stock Information
- Founded
- BELFA 1949
- GPCR 2016
- Country
- BELFA United States
- GPCR United States
- Employees
- BELFA N/A
- GPCR N/A
- Industry
- BELFA
- GPCR
- Sector
- BELFA
- GPCR
- Exchange
- BELFA Nasdaq
- GPCR Nasdaq
- Market Cap
- BELFA 1.2B
- GPCR 1.1B
- IPO Year
- BELFA N/A
- GPCR 2023
- Fundamental
- Price
- BELFA $109.87
- GPCR $17.94
- Analyst Decision
- BELFA
- GPCR Strong Buy
- Analyst Count
- BELFA 0
- GPCR 7
- Target Price
- BELFA N/A
- GPCR $76.17
- AVG Volume (30 Days)
- BELFA 7.4K
- GPCR 687.6K
- Earning Date
- BELFA 07-24-2025
- GPCR 08-07-2025
- Dividend Yield
- BELFA 0.22%
- GPCR N/A
- EPS Growth
- BELFA N/A
- GPCR N/A
- EPS
- BELFA 4.05
- GPCR N/A
- Revenue
- BELFA $594,034,000.00
- GPCR N/A
- Revenue This Year
- BELFA $18.21
- GPCR N/A
- Revenue Next Year
- BELFA $7.91
- GPCR N/A
- P/E Ratio
- BELFA $27.10
- GPCR N/A
- Revenue Growth
- BELFA 6.08
- GPCR N/A
- 52 Week Low
- BELFA $53.95
- GPCR $13.22
- 52 Week High
- BELFA $111.56
- GPCR $45.37
- Technical
- Relative Strength Index (RSI)
- BELFA 77.95
- GPCR 31.75
- Support Level
- BELFA $91.40
- GPCR $17.76
- Resistance Level
- BELFA $95.83
- GPCR $20.25
- Average True Range (ATR)
- BELFA 3.15
- GPCR 0.85
- MACD
- BELFA 0.45
- GPCR -0.04
- Stochastic Oscillator
- BELFA 92.86
- GPCR 17.50
About BELFA Bel Fuse Inc.
Bel Fuse Inc designs and manufactures electronic components that protect and connect electronic circuits. Its product portfolio is divided into three categories: magnetic solutions, power solutions & protection, and connectivity solutions. These products are used for the computer, networking, telecommunications, transportation and defense/aerospace, automotive, medical, and consumer electronics industries. Its geographical segments are the United States, Macao, United Kingdom, Slovakia, Germany, Switzerland, and All other foreign countries. Majority of the revenue is derived from United States.
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.